XML 35 R20.htm IDEA: XBRL DOCUMENT v3.26.1
SHAREHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY
During the three months ended March 31, 2026, we repurchased 1.4 million shares of common stock for $60.0 million under our securities repurchase program (including $0.8 million of repurchases settled in the second quarter of 2026). The Company had remaining repurchase authority of $360.4 million as of March 31, 2026.

During the three months ended March 31, 2026, we issued 0.7 million shares of common stock, net of shares withheld to pay tax withholdings, pursuant to employee benefit plans.

During the three months ended March 31, 2026, dividends declared on common stock totaled $16.4 million ($0.17 per common share). In May 2026, the Company increased its quarterly common stock dividend to $0.18 per share from $0.17 per share.

Accumulated other comprehensive loss, included in shareholders' equity as of March 31, 2026 and December 31, 2025, is comprised of the following (dollars in millions):
March 31,
2026
December 31,
2025
Net unrealized losses on investments having no allowance for credit losses (a)
$(814.7)$(661.6)
Unrealized losses on investments with an allowance for credit losses (1,346.6)(1,193.9)
Change in discount rates for liability for future policy benefits593.2 421.1 
Change in instrument-specific credit risk for market risk benefits1.6 0.9 
Deferred income tax assets348.9 318.5 
Accumulated other comprehensive loss$(1,217.6)$(1,115.0)
___________
(a)     The amortized cost and fair value of fixed maturity securities, available for sale, for which we have elected the fair value option were $13.4 million and $14.2 million, respectively, as of March 31, 2026. Accordingly, the net unrealized losses associated with these investments are excluded from accumulated other comprehensive loss. The amortized cost and fair value of fixed maturity securities, available for sale, for which we have elected the fair value option were $12.0 million and $13.0 million, respectively, as of December 31, 2025.